The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $564,480 Blanket Purchase Agreement (BPA) contract to Tosoh Bioscience, Inc. for the provision of CPRR HBA1C reagents and analyzers over a 5-year period. Tosoh Bioscience, an incumbent contractor, will deliver these critical laboratory products and services to support diabetes care management and clinical pathology programs across the VA-VHA's Veterans Integrated Service Network 2, which encompasses medical facilities in northern California and northern Nevada. The contract utilizes the General Services Administration (GSA) Schedule 66-III for Critical Analyzers, Laboratory, and involves firm fixed-price task orders issued against the BPA to procure the specialized HbA1c testing equipment and supplies on an as-needed basis. No set-aside designations were applied to this single-award IDV contract, which will be performed at Tosoh Bioscience's location in South San Francisco, California.
Additionally, the VA-VHA has issued several task orders against the $564,480 BPA, including a $113,000 call for CPRR HBA1C reagents and analyzers through September 2024, a $20,160 call through September 2023, a $26,751.85 call through September 2027, a $34,776 call through September 2023, and a $32,760 call through September 2023. These task orders further demonstrate the VA-VHA's continued need for Tosoh Bioscience's products and services to support its diabetes patient monitoring and care initiatives within the Veterans Integrated Service Network 2.
Generated 6/11/24, 3:01 PM